USANA Health Sciences, Inc.
USNA
$27.18
$0.080.30%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -73.43% | -6.52% | -39.67% | -10.04% | 31.04% |
| Total Depreciation and Amortization | 20.80% | 7.75% | 10.91% | -2.68% | -7.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.41% | -3.07% | 21.68% | -20.04% | -57.10% |
| Change in Net Operating Assets | -2,423.39% | 970.24% | 44.95% | 43.17% | -101.87% |
| Cash from Operations | -77.77% | 32.83% | -16.34% | 37.79% | -35.69% |
| Capital Expenditure | 75.40% | -64.99% | 25.99% | -51.92% | -122.95% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -100.00% | -- | -33.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -70.20% | 31.55% | -- |
| Cash from Investing | -2,701.67% | -60.80% | -963.69% | -20.43% | -123.10% |
| Total Debt Issued | 2,803.79% | -- | -79.47% | -- | -- |
| Total Debt Repaid | -- | -- | -96.80% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 44.78% | 99.32% | 43.64% | -336.32% | 10.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,384.80% | 99.33% | -2,360.00% | -273.43% | 538.67% |
| Foreign Exchange rate Adjustments | -267.57% | 341.38% | 79.96% | -582.15% | 3.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -882.28% | 373.21% | -11.06% | -130.37% | -42.81% |